|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00460 SIHUAN PHARM
Nominal 
0.740 +0.010 (+1.370%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 2,181,189 | -33.728% | 3,291,270 | 2,464,226 | 2,886,979 | 2,917,405 | |
| Cost of Sales | (693,608) | -17.697% | (842,754) | (549,777) | (592,052) | (538,317) | |
| Gross Profit | 1,487,581 | -39.246% | 2,448,516 | 1,914,449 | 2,294,927 | 2,379,088 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | (276,464) | -- | |
| Change in FV & Impairment on Others | (1,727,119) | 1215.429% | (131,297) | -- | (3,695,039) | -- | |
| Profit / (Loss) on Disposal | -- | -- | 59,228 | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | 72,307 | -- | -- | |
| Share of Results of Asso. & JCEs | (80,875) | -49.001% | (158,581) | (13,064) | (7,190) | (7,718) | |
| Profit / (Loss) before Taxation | (2,122,778) | -- | 486,049 | 765,844 | (2,466,923) | 2,012,165 | |
| Taxation | (196,794) | -22.301% | (253,279) | (219,040) | (290,388) | (332,804) | |
| Profit / (Loss) from Discontinued Operations | 36,296 | -- | -- | (34,917) | -- | -- | |
| Non-controlling Interests | 368,358 | 100.479% | 183,739 | (38,505) | 3,979 | (59,405) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (1,914,918) | -- | 416,509 | 473,382 | (2,753,332) | 1,619,956 | |
| Net Finance Costs / (Income) | 64,382 | -- | (44,637) | (127,511) | (164,875) | (158,498) | |
| Depreciation & Amortisation | 99,150 | -67.110% | 301,463 | 265,225 | 354,697 | 307,241 | |
| Directors' Emoluments | -- | -- | 26,895 | 24,153 | 22,796 | 25,828 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | -20.520 | -- | 4.420 | 5.000 | -29.100 | 17.100 |
| DPS (cts) | 6.500 | -- | 10.800 | 15.000 | 1.700 | 1.700 |
| Dividend Payout Ratio (%) | -- | -- | 244.344% | 300.000% | -- | 9.942% |
| Cash flow per share ($) | 0.005 | -- | 0.071 | 0.024 | 0.150 | 0.189 |
| NBV per share ($) | 0.508 | -- | 0.888 | 0.971 | 1.015 | 1.321 |
| Remarks: | Real time quote last updated: 09/06/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -1,914,918 |
| %Change | -- |
| EPS / (LPS) | RMB -0.205 |
| NBV Per Share (¥) | RMB 0.508 |